ASCENDIS HEALTH LIMITED - Dealings in securities by an associate of directors
ASC 201804090047A
Dealings in securities by an associate of directors
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis” or “the Company”)
Dealings in securities by an associate of directors
In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by an associate of directors, is disclosed:
Directors: Gary Shayne and Crispian Dillon
Name of Associate Coast2Coast Capital Proprietary Limited Group (“C2C”)
Nature and extent of interest: Indirect beneficial (through C2C, in which directors Gary
Shayne and Crispian Dillon currently have an 85% and 15%
indirect beneficial interest, respectively).
Class of shares: Ordinary shares
Nature of transaction: Off-market purchase
Written clearance obtained: Clearance was obtained from the Chairman
Date of transaction: 22 March 2018
Number of shares: 210,000 shares
Purchase price per share: R9.00
Total value of transaction: R1,890,000
Bryanston
9 April 2018
Sponsor
Questco Corporate Advisory Proprietary Limited
Date: 09/04/2018 04:48:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
